{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:38Z","timestamp":1787771258893,"version":"build-2784847793"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Data about the oncological outcomes in women with borderline ovarian tumor (BOT) undergoing uterine-sparing surgery without ovarian preservation are poor. We aimed to assess the oncological outcomes\u00a0in women with BOT undergoing uterine-sparing surgery without ovarian preservation. A multi-center observational retrospective cohort study was performed including all consecutive postmenopausal patients who underwent surgical treatment for BOT at three tertiary level referral centers for gynecologic oncology from January 2005 to December 2016. Patients were divided into two groups for comparisons: patients undergoing hysterectomy (hysterectomy group) and patients undergoing uterine-sparing surgery (no hysterectomy group). Study outcomes were disease-free survival (DFS), overall survival (OS), disease-specific survival (DSS) and surgical complications rate. Ninety-eight patients were included: 44 in the hysterectomy group and 54 in the no hysterectomy group. The 5- and 10-year DFS rates were 97.7% (95% CI: 84.9\u201399.7) and 92.3% (95% CI: 69.7\u201398.2), in the hysterectomy group, and 86.8% (95% CI: 74.3\u201393.5) and 86.8% (95% CI: 74.3\u201393.5), in the no hysterectomy group, respectively, without significant differences (p=0.16). Hazard ratio for DFS was 0.26 (95% CI: 0.06\u20131.68) for the hysterectomy group. The 5- and 10-year OS rates were 100.0% (95% CI: -) and 100.0% (95% CI: -), in the hysterectomy group, and 98.2% (95% CI: 87.6\u201399.7) and 94.4% (95% CI: 77.7\u201398.7), in the no hysterectomy group, respectively, without significant differences (p=0.23). No significant difference in complication rate was reported among the groups (p=0.48). As hysterectomy appears to not impact survival outcomes of women with BOT, it might be avoided in the surgical staging.<\/jats:p>","DOI":"10.3389\/fonc.2022.1009341","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T05:32:25Z","timestamp":1666848745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study"],"prefix":"10.3389","volume":"12","author":[{"given":"Diego","family":"Raimondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Raffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Maletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Restaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Mascilini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Trozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Travaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Driul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Seracchioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suronc.2015.11.004","article-title":"Is there a justification for hysterectomy in patients with borderline ovarian tumors","volume":"25","author":"Ouldamer","year":"2016","journal-title":"Surg Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/s0015-0282(01)02842-4","article-title":"Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors","volume":"76","author":"Seracchioli","year":"2001","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100730","article-title":"Can we safely forgo hysterectomy in non-fertility-sparing surgery for borderline ovarian tumors","volume":"36","author":"Hill","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Arbeitsgmeinschaft gyn\u00e4kologische onkologie (AGO) study group. borderline tumours of the ovary: A cohort study of the arbeitsgmeinschaft gyn\u00e4kologische onkologie (AGO) study group","volume":"49","author":"Du Bois","year":"2013","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"19","author":"Pfister","year":"2021","journal-title":"J Nat Comp Cancer Net"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(03)00160-2","article-title":"Safety of conservative management and fertility outcome in women with borderline tumors of the ovary","volume":"79","author":"Donnez","year":"2003","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.03.010","article-title":"Fertility and recurrence results of conservative surgery for borderline ovarian tumors","volume":"97","author":"Boran","year":"2005","journal-title":"Gynecol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603139","article-title":"Clinical outcome and risk factors for recurrence in borderline ovarian tumors","volume":"94","author":"Yokoyama","year":"2006","journal-title":"Br J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.00864.x","article-title":"Ovarian tumors of borderline malignancy: A review of 247 patients from 1991 to 2004","volume":"17","author":"Wong","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.03.019","article-title":"A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors","volume":"110","author":"Ren","year":"2008","journal-title":"Gynecol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2011.04.003","article-title":"Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors","volume":"74","author":"Tsai","year":"2011","journal-title":"J Chin Med Assoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e3182129842","article-title":"Fertility-sparing surgery for borderline ovarian tumors: oncologic safety and reproductive outcomes","volume":"21","author":"Song","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3381-7","article-title":"Retrospective evaluation of borderline ovarian tumors: Single center experience of 183 cases","volume":"291","author":"Gungor","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23021","article-title":"The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182841594","article-title":"Complications of hysterectomy","volume":"121","author":"Clarke-Pearson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"ijgc-2019-000308","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","author":"Colombo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gofs.2020.01.016","article-title":"Tumeurs fronti\u00e8res de l\u2019ovaire. recommandations pour la pratique clinique du CNGOF \u2013 prise en charge th\u00e9rapeutique des stades pr\u00e9coces [Borderline ovarian tumours: CNGOF guidelines for clinical practice - therapeutic management of early stages]","volume":"48","author":"Canlorbe","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.01.019","article-title":"The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis","volume":"165","author":"Raimondo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"12","author":"Von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000282","article-title":"Gynecologic cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)","volume":"24","author":"Harter","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"B23","first-page":"38","article-title":"ASA provides examples to each ASA physical status class","volume":"79","author":"Abouleish","year":"2015","journal-title":"ASA Newslett"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000503095","article-title":"Performance status assessment by using ECOG (Eastern cooperative oncology group) score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-016-2040-8","article-title":"Ovarian borderline tumors in the 2014 WHO classification: Evolving concepts and diagnostic criteria","volume":"470","author":"Hauptmann","year":"2017","journal-title":"Virchows Arch"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.06.028","article-title":"Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors","volume":"211","author":"Bendifallah","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101961","article-title":"Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group","volume":"50","author":"Sangnier","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.12.024","article-title":"Recurrence after cystectomy for borderline ovarian tumors: Results of a French multicenter study","volume":"13","author":"Poncelet","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.02.017","article-title":"The effect of hysterectomy on survival of patients with borderline ovarian tumors","author":"Menczer","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1009341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T05:32:27Z","timestamp":1666848747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1009341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":31,"alternative-id":["10.3389\/fonc.2022.1009341"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1009341","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"article-number":"1009341"}}